This content is machine translated Severe asthma Anti-IL-5/-5Rα biologics impress in the real world Three biologics targeting interleukin 5 (IL-5) or its receptor (IL-5Rα) are approved for use in patients with severe asthma. In a meta-analysis, Greek scientists have now investigated the clinical response...…
View Post 3 min This content is machine translated Joint SSORL/SSAI Meeting Biologics in asthma and aluminum adjuvants in vaccines The fact that asthma is a very heterogeneous disease is especially true for patients with severe asthma. Additional new drugs are needed mainly for patients whose severe asthma is not…
